Growth hormone axis
Hexarelin
Also called Examorelin, EP-23905
per administration
A human trial worked out how much to take and how often, so a dosing schedule is shown.
Quick start
Hexarelin at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.
- Typical dose
- 105–210 mcg per administration
- How often
- Every day
- Where
- Subcutaneous — abdomen, thigh, or upper arm Sites and rotation
- Time to steady level
- ~5 hours — about five half-lives
- Storage
- Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details
A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.
Key properties
Molecular reference data.
- Formula
- C47H58N12O6
- Mol. weight
- 887 Da
- CAS
- 140703-51-1
- PubChem CID
- 6918297
External references
Work out your draw
These numbers are a starting point — change any of them.
Vial label
Copy this into your label printer.
Published research contexts for Hexarelin describe 105–210 mcg per administration. Descriptive only, not a recommendation.
About 55 minutes; longer-acting than GHRP-2 or GHRP-6 but still short.
Dosing schedule
How Hexarelin is commonly stepped up, for reference only.
These are commonly-discussed research protocols shared for educational reference. This is not medical advice and is not a substitute for guidance from a qualified professional.
| Phase | Amount | Frequency | Route |
|---|---|---|---|
| Reported dose-response rangeThe amounts Imbimbo's dose-response study administered; the higher step gave a larger growth-hormone rise. A short-acting secretagogue. | 1.5–3 mcg/kg (about 105–210 mcg for a 70 kg adult) | Once daily | SubQ |
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 5hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Imbimbo BP et al., JCEM 1994;78:693A subcutaneous dose-response study of hexarelin at 1.5–3 mcg/kg, with growth-hormone release rising across the range in healthy volunteers.